Authors


Katrina Celis, MD

Latest:

Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care

The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.



Naeem Khan, MD

Latest:

Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES Trial

The vice president of AstraZeneca’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.


Marwan Sabbagh, MD

Latest:

The Future Outlook for Alzheimer’s Disease

Sharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.


Kathleen Hawker, MD

Latest:

Kathleen Hawker, MD: Clinical Findings for Satralizumab in Treating NMOSD

The group medical director of neuroscience at Genentech spoke to the findings recently presented at the 6th Annual Meeting of the European Academy of Neurology.


Stuart H. Isaacson, MD, FAAN

Latest:

Patient-Centric Care and Shared Decision-Making in Parkinson’s Disease

Dr. Isaacson discusses how patient-centric, personalized care in Parkinson's Ddisease (PD) focuses on tailoring treatment to individual patient needs and preferences, contrasting with pharmacological-centered care by emphasizing shared decision-making and the holistic integration of wellness strategies.



Dawn Buse, PhD

Latest:

Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

The clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.


Amy Sullivan, PsyD

Latest:

Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple Sclerosis

The Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.


Jeff Waugh, MD, PhD

Latest:

Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

Despite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.


Patricia K. Coyle, MD

Latest:

Future Directions and Unanswered Questions Regarding S1P Modulator Receptors

In this episode, Patricia Coyle, MD, FAAN, gave clinical insight on some of the next steps regarding S1P-modulating therapies, including some of the advantages of newer generation agents and the need for future studies to investigate benefits and limitations to each.



Dominic Pelle, MD

Latest:

Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine Surgery

The spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.



James Leverenz, MD

Latest:

Promising Diagnostic Approaches Emerging for Brain Pathologies: James Leverenz, MD

The director of the Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic discussed new diagnostic techniques that show promise for advancing the understanding of brain pathologies like Alzheimer and Lewy Body diseases. [WATCH TIME: 3 minutes]


Jerrold L. Vitek, MD, PhD

Latest:

Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS Technology

The professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.


Mia Minen, MD, MPH

Latest:

Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache

Mia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.


Eugenia Trushina, PhD

Latest:

Eugenia Trushina, PhD: Communication and Learning Through Collaboration

For the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.


Chia-Chun Chiang, MD

Latest:

Narrowing Down Effective Medications, Classes of Treatments for Migraine: Chia-Chun Chiang, MD

The associate professor of neurology at Mayo Clinic Rochester discussed specific findings from a simultaneous comparison of migraine medications in which certain treatments and classes were more effective. [WATCH TIME: 3 minutes]


Ronald C. Petersen, MD, PhD

Latest:

The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhD

The director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]



David K. B. Li, MD, FRCPC

Latest:

The Importance of a Globally Aligned, Standardized MRI Protocol for MS

Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.


Clive Ballard, MD

Latest:

Pimavanserin Safety Data and Future Research: Clive Ballard, MD

Clive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.


Ari Green, MD, MCR

Latest:

Ari Green, MD, MCR: Remyelination in Multiple Sclerosis

The medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.


Danielle Andrade, MD, MSc

Latest:

Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPC

The director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]




Deborah Friedman, MD, MPH

Latest:

Deborah Friedman, MD, MPH: Coordinating Care in Telemedicine

The professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.


Trevor Dyson-Hudson, MD

Latest:

Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord Injury

The director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.


Aaron Boster, MD

Latest:

Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.

© 2024 MJH Life Sciences

All rights reserved.